Ultrasound technology developer dBMEDx has received clearance from the U.S. Food and Drug Administration (FDA) for its new bladder scanner.
BBS Revolution allows users to measure patients' bladder volume noninvasively, a key component of catheter-associated urinary tract infection prevention programs, according to dBMEDx. In fact, the U.S. Centers for Medicare and Medicaid Services (CMS) is reducing payments by 1% for hospitals with a high number of hospital-acquired conditions, which include catheter-associated urinary tract infections.
The device offers a way for hospitals to determine whether a patient actually needs a catheter or not, the company said.
